IP Library Granted Patent US 9,765,365
Granted Patent B2
US 9,765,365 · App. 14/991,512 · Granted Sep 19, 2017

Integration of a polynucleotide encoding a polypeptide that catalyzes pyruvate to acetolactate conversion

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,765,365
App. No.
14/991,512
Granted
Sep 19, 2017
Kind
B2
Abstract

The invention relates to recombinant host cells having at least one integrated polynucleotide encoding a polypeptide that catalyzes a step in a pyruvate-utilizing biosynthetic pathway, e.g., pyruvate to acetolactate conversion. The invention also relates to methods of increasing the biosynthetic production of isobutanol, 2,3-butanediol, 2-butanol or 2-butanone using such host cells.

Claims (23)

1. A recombinant host cell comprising:

(a) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of pyruvate to acetolactate wherein the polypeptide is an acetolactate synthase from Bacillus subtilis, Klebsiella pneumonia, Lactococcus lactis, Staphylococcus aureus, Listeria monocytogenes, Streptococcus mutans, Streptococcus thermophiles, Vibrio angustum , or Bacillus cereus;

(b) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of acetolactate to 2,3-dihydroxyisovalerate wherein the polypeptide is a ketol-acid reductoisomerase and the ketol-acid reductoisomerase has at least 95% identity to SEQ ID NO: 224;

(c) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of 2,3-dihydroxyisovalerate to α-ketoisovalerate wherein the polypeptide is a dihydroxyacid dehydratase from Escherichia coli, Bacillus subtilis, Methanococcus maripaludis , or Streptococcus mutans ; and

(d) a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion of α-ketoisovalerate to isobutyraldehyde wherein the polypeptide is a branched-chain α-keto acid decarboxylase and the branched-chain α-keto acid decarboxylase has at least 95% identity to SEQ ID NO: 247.

2. The recombinant host cell of claim 1 further comprising a polynucleotide encoding a polypeptide which catalyzes the substrate to product conversion isobutyraldehyde to isobutanol wherein the polypeptide is an alcohol dehydrogenase from Achromobacter xylosoxidans or Beijerinkia indica.

3. The recombinant host cell of claim 1 , wherein the acetolactate synthase has at least 95% identity to SEQ ID NO: 4.

4. The recombinant host cell of claim 1 , wherein the ketol-acid reductoisomerase has at least 97% identity to SEQ ID NO: 224.

5. The recombinant host cell of claim 1 , wherein the dihydroxyacid dehydratase has at least 95% identity to amino acid sequence of SEQ ID NO: 89.

6. The recombinant host cell of claim 1 , wherein the branched-chain α-keto acid decarboxylase has at least 97% identity to SEQ ID NO: 247.

7. The recombinant host cell of claim 2 , wherein the alcohol dehydrogenase has at least 95% identity to an amino acid sequence selected from SEQ ID NOs: 36 or 237.

8. The recombinant host cell of claim 1 , wherein expression of pyruvate decarboxylase in the recombinant host cell is decreased or substantially eliminated.

9. The recombinant host cell of claim 1 , wherein the recombinant host cell comprises a deletion, mutation, and/or substitution in an endogenous polynucleotide encoding a polypeptide having pyruvate decarboxylase activity.

10. The recombinant host cell of claim 1 , wherein expression of glycerol-3-phosphate dehydrogenase in the recombinant host cell is decreased or substantially eliminated.

11. The recombinant host cell of claim 1 , wherein expression of Fe Repressor of Activation-2 (Fra2) in the recombinant host cell is decreased or substantially eliminated.

12. The recombinant host cell of claim 1 , wherein expression of pyruvate decarboxylase, glycerol-3-phosphate dehydrogenase, and Fe Repressor of Activation-2 (Fra2) in the recombinant host cell is decreased or substantially eliminated.

13. The recombinant host cell of claim 1 , wherein the recombinant host cell is selected from bacterium, cyanobacterium, filamentous fungus, or yeast.

14. The recombinant host cell of claim 1 , wherein the recombinant host cell is selected from the group consisting of Clostridium, Zymomonas, Escherichia, Salmonella, Rhodococcus, Pseudomonas, Bacillus, Lactobacillus, Enterococcus, Alcaligenes, Klebsiella, Paenibacillus, Arthrobacter, Corynebacterium, Brevibacterium, Pichia, Candida, Hansenula, Issatchenkia, Kluyveromyces , and Saccharomyces.

15. The recombinant host cell of claim 1 , wherein the recombinant host cell is selected from the group consisting of Saccharomyces cerevisiae, Schizosaccharomyces pombe, Kluyveromyces lactis, Kluyveromyces thermotolerans, Candida glabrata, Candida albicans, Pichia stipitis , and Yarrowia lipolytica.

16. A method comprising

(a) providing the recombinant host cell of claim 1 ; and

(b) contacting the recombinant host cell with a fermentable carbon substrate under conditions whereby a product is produced.

17. The method of claim 16 , wherein the product is isobutanol.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 30, 2021
From: BUTAMAX ADVANCED BIOFUELS LLC
To: GEVO, INC.
Reel/Frame 057677/0477 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 24, 2021
From: ANTHONY, LARRY CAMERON; MAGGIO-HALL, LORI ANN
To: BUTAMAX(TM) ADVANCED BIOFUELS LLC
Reel/Frame 057267/0570 →